chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 14-APR-206 (reported as "today"), the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously (which had a lot # of L040445 and an expiration date of 15-JAN-2017; however dose, dosage number and anatomical location were not reported). While the vaccination was taking place, about a quarter of the ZOSTAVAX dose leaked out of the syringe onto the patient's arm. Nevertheless, no adverse effects were reported. Additional information has been requested.
I felt nauseous after the injection and had pain in my arm, neck and shoulder for several days. I had a neck MRI on 4/3/2017 which showed a bulging disc. After physical therapy, the neck pain subsided somewhat but the shoulder continued to hurt. I saw a sports med doctor and was diagnosed with "frozen shoulder". X-rays showed no evidence of arthritis. I went to physical therapy for 7 months and saw improvement. After more than a year, I still have some shoulder pain and less range of motion than is normal. I am no longer receiving physical therapy but do have a lasting effect. I have also tried chiropractic care, massage and acupuncture.
The patient experienced diaphoresis, nausea, and dizziness. The patient had no trouble breathing, so I gave him a cold compress and he sat for 30 minutes drinking water after the shot. He felt better at the end and felt comfortable leaving. I followed up with him in 2 hours after he left and he said that he felt much better. I told him to seek medical attention if he had further symptoms that were unresolved.
STRONG PERSISTENT HEADACHE GENERALIZED MYALGIA BACK PAIN UNQUANTIFIED FEVER WEAKNESS
7-2-18, Today vaccine site feels bruised and sore. Vaccine site swollen and puffy. Neck muscle that is always tight, feels more tight.
12x7cm indurated warm area at site of DTaP within 24 hours of imm. Happened with prev. shot.
when pt returned for 2nd vax; c/o intense extremity pain like bones were being scraped which began 2 days p/vax; sx had resolved by the time pt seen;
Numbness and tingling in L arm post Covid vaccine injection; tingling in L arm post Covid vaccine injection; This is a spontaneous report from a contactable other hcp (Nurse) (patient). This report was received via a sales representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on an unspecified date at dose number unknown, single for covid-19 immunisation. Medical history included numbness and tingling due to spinal cord compression. Concomitant medications were not reported. On an unspecified date the patient experienced numbness and tingling in L arm post covid vaccine injection. Description of Event: Numbness and tingling in L arm post Covid vaccine injection. Hx of numbness and tingling due to spinal cord compression. Event took place after use of product. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "wasn't feeling good and and shoveling snow" (unspecified if ongoing), notes: wasn't feeling good and and shoveling snow; "chest pain" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "Chills", "DVT", "arm pain", "blood clot". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt came to ER c/o URI onset 4 days prior.  Known to be covid positive.
Client reported to have a reaction to 1st COVID vaccine of Moderna (Lot# 017C21A) administered on 05/03/21. Client states having intermittent "numbness and tingling" on the left calf since the first dose. Client states there is no pain, but more of a discomfort. Client states after 1st dose, Client felt "muscle tension" from the vaccination site (left arm) to left calf. Client states she has not followed up with primary care provider. RN and PHN educated Client about following up with primary care provider. Client reports a medical history of hypertension and is currently taking medication from another country to treat it. Client has no known allergies. Elevated to medical team consult and was approved to get 2nd COVID vaccine of Moderna today (05/31/21).
very sharp pain in his right arm jumped up from his seat may have been because of the injection technique by the vaccinator; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (very sharp pain in his right arm jumped up from his seat may have been because of the injection technique by the vaccinator) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE PAIN (very sharp pain in his right arm jumped up from his seat may have been because of the injection technique by the vaccinator). At the time of the report, VACCINATION SITE PAIN (very sharp pain in his right arm jumped up from his seat may have been because of the injection technique by the vaccinator) outcome was unknown.            The patient does not report any adverse events or side effects to his first Moderna Covid-19 vaccine.  The patient received his second Moderna Covid-19 vaccine in his right arm shoulder deltoid muscle.  No concomitant medication was reported.    No treatment information was reported.
COPD (unable to breathe on routine visit requiring benedryl and another duoneb)
Patient received Booster dose at 4 months instead of 5 months. When making the appt, the parent marked patient was immunocompromised.
HepA given (L) arm then GARDASIL in (R) arm. After needle removed from (R) arm, loss of consciousness -> stiffening -> tonic-clonic movements 1-2 minutes.
Vaccination administered too low on the left arm. Possibility of subcutaneous administration. Site warm, red, and itchy within 30 minutes of administration.  By 4 hours post vaccine, knot noted under the injection site, redness decreasing.
Chills starting about 24 hr after receiving vaccine then a fever of 102 which decreased to 100 by bed time and then was back to normal the next day.   Very tiered after fever was back to normal which lasted for aprox. 24 hours.  3 days after vaccine I was feeling fine again
Patient believes vaccine was administered too close to or near the joint; sore arm; sore shoulder; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (sore arm), ARTHRALGIA (sore shoulder) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Patient believes vaccine was administered too close to or near the joint) in a 78-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7165B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced PAIN IN EXTREMITY (sore arm) and ARTHRALGIA (sore shoulder). On 28-Oct-2022, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Patient believes vaccine was administered too close to or near the joint). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), ARTHRALGIA (sore shoulder) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Patient believes vaccine was administered too close to or near the joint) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.
Patient felt nauseous, light headed, and heart racing. Patient stated that her heart racing was not abnormal for her. Patient laid down on ground, drank some water, used a cold compress, and felt better. Patient left to hospital at the end however.
day of shot 5pm chills sweats, went to bed. 2nd day did nothing chills sweats . 3rd day did not feel to do anything.5th day still did nothing sore muscles and joints,weak. After another week I did not feel like eating stomach was upset, loss 6-8  pounds . Went to doctor who gave shot he said my stomach was inflamed. Told me to take omeprazole 40mg . seemed to fix stomach. Finally back to normal.  In past years before 2019 I always get flu symptoms the day of the shot but next day ok never this bad like 2019. I feel I should not get the high dose.
Chills for about 6 hrs Fatigue/ muscle aches for 36hrs Mild Pain at injection site for 36hrs Symptoms went away with bed rest after 36hrs. No treatment required.
local redness & swelling site of vax w/in 15 min plus wheezing & edema of rt eyelid;improved w/epi & DPH
Started with pain in her back along her spine along - back, neck pain, hip pain. With weakness of muscle. Office note-Seen by doctor on 4/12/07, seen by rheumatologist on 5/10/07. still with pain in spine, still no pain. Office visit note for 4/18/07-C/O severe lower back pain started on same day she received vaccine. Mild right shoulder pain. PE: moderate tenderness on pressure of spinaly bony ridge from lower thoracic to sacral area. No warmth redness or swelling of back. Gait guarded and back flexion limited due to back pain. Assessment: severe back pain due to underlying genetic/immunologic problem of chronicity family history and inflammatory bowel disease. ANA positive suggests autoimmune phenomenon HLS B27 genotype would be strong consideration. Rheumatology consult
Chills, cold sweats, dizziness, fatigue, muscle weakness, other dehydration symptoms
Rash on both forearms.; This is a spontaneous report from a contactable consumer (patient himself). A 70-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number was not reported) via an unspecified route of administration in left arm on 03Mar2021 at 15:00 as 2nd dose single dose for COVID-19 immunization. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6202 Expiry date: unknown) via an unspecified route of administration on 10Feb2021 at 09:00 for COVID-19 immunization. The patient's medical history included pulmonary resection. The patient had not received any other vaccines within 4 weeks. The patient was not diagnosed prior and since the vaccination with COVID-19. The patient's concomitant medications was not reported. The patient experienced rash on both forearms on 05Mar2021 at 13:00. The patient had not received treatment for the adverse events. The outcome of event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Rash & bruise near injection site. About 3 inches x 2 inches in size.
Initially patient had simply local soreness at injection site.  That resolved, and about 3 days later noted swollen lymph node in lower anterior cervical chain on same side as injection.  About the same time she developed swelling, redness, warmth, and expanding soreness in the L deltoid area. I saw her on day 2 of that.  Exam showed she was afebrile, and the area was partly indurated (no fluctuance).  Entire red/swollen area measured 15 x 9 cm.  Lymph node was about 1 cm, maybe a little smaller.
Tinnitus, dizziness, head pressure, weird sensations and paresthesia of the left cheek
Damaged or Broken Ampule; 1st dose administered from a vial that was leaking around the stopper; A spontaneous report was received from a nurse concerning 67-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and reported product administration error (1st dose administered from a vial that was leaking around the stopper) and damaged or broken Ampule (Damaged product).  The patient's medical history was not provided. No relevant concomitant medications were reported.  The patient received the first of the two planned doses of mRNA-1273 on 24-FEB-2021 (Batch: 012a21a, Expiry date: 17-Aug-2021) intramuscularly on left arm for prophylaxis of COVID-19 infection.   It was reported that reporter opened the vial and it popped cracked (Damaged product) 1st dose administered from a vial that was leaking around the stopper (product administration error ).  Treatment details included none.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome was recovered for product administration error  and not recovered for damaged product.  The assessment was not provided for the event.; Reporter's Comments: This report refers to a case of out of specification product use and Product damaged for mRNA-1273, lot # 012a21a, with no associated AEs.
received BOOSTRIX, subject to temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 24th February 2022, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not reported.  The reporter did not have patient identifiers. The health care professional reported that a patient received Boostrix that was subject to temperature excursion, which led incorrect storage of drug. The reporter consented to follow-up. The case was linked with case US2022039272 and US2022AMR040208, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022039272:Same reporter US-GLAXOSMITHKLINE-US2022AMR040208:Same reporter
This is a spontaneous report from a contactable Other HCP. A 53-year-old female patient of an unspecified ethnicity received PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN) at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced edema and dermatitis on an unspecified date with outcome of unknown.
Reports swelling in left upper arm from elbow to shoulder with pain and itching at site. Went to ER and given steroids. No systemic or airway involvement.
On 1/04/10 ready to give pt. injection. Patient then asked for nasal spray. Redid form and gave pt nasal spray. Nasal spray is not indicated for patients over 49 years old. Called pt. and asked him to come in for shot after calling health dept. pt said he would come in but has not shown up in 10 days.
Warm to the touch; Little tender; Hard to the touch; Red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), TENDERNESS (Little tender), VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), TENDERNESS (Little tender), VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Red spot at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), TENDERNESS (Little tender), VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  Patient had took several medications for the treatment.
Simple motor tic- shrugging shoulder, persistent x 1 month, 1st noted approximately 2d after Gardasil vaccine.
This spontaneous case, initially received from a pharmacist on 04-Sep-2018, concerns a 61-year-old, adult, male patient. The patient did not have any relevant medical history. The patient did not receive any concomitant medications. On 04-Sep-2018, the patient (under age 65 years) was accidentally administered FLUAD TIV [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 250783, expiry date: 30-Apr-2019] (explicitly coded as inappropriate age at vaccine administration). The Seqirus confirmed that, batch number (250783) was a valid FLUAD NH1819 TIV PFS LL 10X1 batch number. The patient did not complain of any adverse events. The reporter assessed the case as non-serious. This case was cross-linked with the case 201803731 reported by the same reporter. Update received on 07-Sep-2018: Non-significant case correction (IRD: 04-Sep-2018): The Seqirus confirmed that, batch number (250783) was a valid FLUAD NH1819 TIV PFS LL 10X1 batch number. Hence, the batch number (250783) of the suspect product was added in the product tan and the narrative was amended accordingly.
My son is currently experiencing fever, chills, aches and vomiting.  My wife is experiencing the same effects and I will be entering another report for her  We believe the doesages were left out or that the individual at the pharmacy specifically choose to give us a batch that was outdated
t103, febile, very fussy phoned in a rx for ped advil susp & pedialyte;
After receiving injections patient was sitting in chair while I was completing immunization paper work. Looked over and patient was slumping down and fell out of chair, fainted and hit head on floor. Patient was assisted up, ice pack was applied to head, no open wounds no lumps noted.
After 5th dose of DTAP pt c/o redness & swelling at injection site; Pt. was seen in the office 5.7.10 (3 days post injection).  Diagnoses:  Vaccine reaction.
This is a spontaneous report from a contactable consumer. A 74-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, formulation: solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date in Feb 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Reportedly, on an unspecified date, after the patient received the first dose of the Pfizer-BioNTech COVID-19 vaccine, he had hives and was not able to get the second dose. The reporter asked if the patient could still get the vaccine as doctors could not give an answer. The reporter wanted to know an answer as the healthcare providers were not helping them and was frustrated. The outcome of the event: unknown. Information on lot number/batch number requested.
Baby received vaccines on 10/7; mom states (L) leg is reddened and sl edematous. Increased irritability and crying on the evening of 10/8.
Approx. 5 minutes after receiving vaccines, patient noted by father and immunization tech, to have body shaking that lasted for < 10 seconds. No postictal state, patient placed in trendelenburg position and given supplemental O2. He was pale, but responsive. No LOC. Vital signs were stable.
12 hours post vaccine, 05/15/2021-I started having rash, my bones were sore, it hurt to walk, my feet started to swell, it gradually started getting harder to walk. My period became irregular. I started to experience lower abdominal cramping. I am still having issues with my feet and walking. 72 hours after the vaccine, I started my period, I was not scheduled to have it for another 2 weeks. After the vaccine my periods have been excruciating painful. I double up in pain. The irregular periods and the pain have been occurring since after the 1st dose and continued after the 2nd dose. I did not have the pain prior to the vaccine. Within 48 hours, after having vaccine, I started having a rash on my torso and also on my legs at one point in my inner thigh area. I have been to the doctor probably a dozen times before I moved out of state. She told me to monitor my symptoms and keep a booklet.2-day post vaccine- nasal drain, sore throat, no fever. I did COVID-19 test- negative. The symptoms went on for like a month-dry cough, lingering, unproductive cough that did not go away. The doctor put me on Mucinex for 9 or 10 days. The cough eventually went away. I had nasal congestion, drainage, and felt like an elephant sitting on my chest. Increase in diarrhea and that is still an issue. It still going on even taking Imodium AD - hospital version.  I also did a lung function test, and it came back normal. Nobody can tell me why it feels like an elephant is sitting on my chest. The highest temperature I recorded was 99.5 during that month 1/2.  I still have issues with my bones hurting. My bones hurt, not my muscles, it is a weird feeling I never had in my whole life. I also had a lot of mood swings, very bad depression bouts. I have never had a cold that has lasted me that long. My doctor told me it is aftereffects from the vaccine. The symptoms I still am having as of now, 11/19/2021- abdominal pain, diarrhea, headaches, my bones still hurt my feet are still having issues, they still hurt and swell at times, and I am still having period issue.
Right thigh urticaria at site of injections.  Lungs clear.  Given Benadryl 1 1/2 tsp x1.  Rechecked after 20 minutes, rash resolved with exception of one hive at varivax administration site.  Decreased redness and size of hive.
Went into ER after what the ER physician determined were myoclonic jerks and ruled out seizures.
Patient received the first dose of the Pfizer covid vaccine on 12/16 and on 12/17 in the afternoon she developed a rash on her chest. She reports the rash was little raised bumps and was itchy and red. The rash extended to her abdomen, back, neck, arms and legs on 12/18-12/19. The rash began to fade on 12/20 and is almost completely gone now 12/22. Patient not treat with rash with any topicals or oral medications.
I received the vaccine and a month later was diagnosed with Grovers disease which is a rash on the back and chest. Seems to me it very coincidental. The only relief that I get is from the drug SORIATANE which may have other adverse effects.  8/6/09 Dermatology consultant records received DOS 7/25/06 to 3/13/09. Assessment: Transient Acantholytic Dermatosis (Grover's Disease). Patient presents with itchy rash on chest and back - folliculitis. Blackheads. Scars on face, scar revision surgery performed.